Lv5
960 积分 2022-04-09 加入
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial
1个月前
已完结
AI-driven protein design
2个月前
已完结
Artificial intelligence in drug development
2个月前
已完结
Kidney Failure Risk Prediction Equations in IgA Nephropathy: A Multicenter Risk Assessment Study in Chinese Patients
3个月前
已完结
Prevalence and Trend of Biopsy-Proven IgA Nephropathy in China: A Systematic Review
3个月前
已完结
Control of adaptive immunity by the innate immune system
4个月前
已完结
CAR T cells produced in vivo to treat cardiac injury
5个月前
已完结
All-atom protein sequence design based on geometric deep learning
5个月前
已完结
Arming Yourself for The In Silico Protein Design Revolution
5个月前
已完结
皖公网安备34019202002308
